Cargando…

Dietary saponins of sea cucumber alleviate orotic acid-induced fatty liver in rats via PPARα and SREBP-1c signaling

BACKGROUND: Nonalcoholic fatty liver disease is the most common chronic liver disease in the world, and is becoming increasingly prevalent. Saponins of sea cucumber (SSC) are proven to exhibit various biological activities. Therefore, the present study was undertaken to examine the effect of saponin...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Xiao-Qian, Wang, Yu-Ming, Wang, Jing-Feng, Xue, Yong, Li, Zhao-Jie, Nagao, Koji, Yanagita, Teruyoshi, Xue, Chang-Hu
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2846940/
https://www.ncbi.nlm.nih.gov/pubmed/20211032
http://dx.doi.org/10.1186/1476-511X-9-25
_version_ 1782179524558979072
author Hu, Xiao-Qian
Wang, Yu-Ming
Wang, Jing-Feng
Xue, Yong
Li, Zhao-Jie
Nagao, Koji
Yanagita, Teruyoshi
Xue, Chang-Hu
author_facet Hu, Xiao-Qian
Wang, Yu-Ming
Wang, Jing-Feng
Xue, Yong
Li, Zhao-Jie
Nagao, Koji
Yanagita, Teruyoshi
Xue, Chang-Hu
author_sort Hu, Xiao-Qian
collection PubMed
description BACKGROUND: Nonalcoholic fatty liver disease is the most common chronic liver disease in the world, and is becoming increasingly prevalent. Saponins of sea cucumber (SSC) are proven to exhibit various biological activities. Therefore, the present study was undertaken to examine the effect of saponins extracted from sea cucumber (Pearsonothuria graeffei) on the preventive activity of fatty liver in rats. METHODS: Male Wistar rats were randomly divided into five groups, including normal control group, fatty liver model group, SSC-treated group with SSC at levels of 0.01%, 0.03% and 0.05%. Model rats were established by administration with 1% orotic acid (OA). After the experiment period, serum total cholesterol (TC), triglyceride (TG), and hepatic lipid concentrations were determined. To search for a possible mechanism, we examined the changes of key enzymes and transcriptional factors involved in hepatic lipids biosynthesis, fatty acid β-oxidation. RESULTS: Both 0.03% and 0.05% SSC treatment alleviated hepatic steatosis and reduced serum TG and TC concentration significantly in OA fed rats. Hepatic lipogenic enzymes, such as fatty acid synthase (FAS), malic enzyme (ME), and glucose-6-phosphate dehydrogenase (G6PDH) activities were inhibited by SSC treatment. SSC also decreased the gene expression of FAS, ME, G6PDH and sterol-regulatory element binding protein (SREBP-1c). Otherwise, the rats feeding with SSC showed increased carnitine palmitoyl transferase (CPT) activity in the liver. Hepatic peroxisome proliferator-activated receptor (PPARα), together with its target gene CPT and acyl-CoA oxidase (ACO) mRNA expression were also upregulated by SSC. CONCLUSIONS: According to our study, the lipids-lowering effect of dietary SSC may be partly associated with the enhancement of β-oxidation via PPARα activation. In addition, the inhibited SREBP-1c- mediated lipogenesis caused by SSC may also contribute to alleviating fatty liver.
format Text
id pubmed-2846940
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-28469402010-03-30 Dietary saponins of sea cucumber alleviate orotic acid-induced fatty liver in rats via PPARα and SREBP-1c signaling Hu, Xiao-Qian Wang, Yu-Ming Wang, Jing-Feng Xue, Yong Li, Zhao-Jie Nagao, Koji Yanagita, Teruyoshi Xue, Chang-Hu Lipids Health Dis Research BACKGROUND: Nonalcoholic fatty liver disease is the most common chronic liver disease in the world, and is becoming increasingly prevalent. Saponins of sea cucumber (SSC) are proven to exhibit various biological activities. Therefore, the present study was undertaken to examine the effect of saponins extracted from sea cucumber (Pearsonothuria graeffei) on the preventive activity of fatty liver in rats. METHODS: Male Wistar rats were randomly divided into five groups, including normal control group, fatty liver model group, SSC-treated group with SSC at levels of 0.01%, 0.03% and 0.05%. Model rats were established by administration with 1% orotic acid (OA). After the experiment period, serum total cholesterol (TC), triglyceride (TG), and hepatic lipid concentrations were determined. To search for a possible mechanism, we examined the changes of key enzymes and transcriptional factors involved in hepatic lipids biosynthesis, fatty acid β-oxidation. RESULTS: Both 0.03% and 0.05% SSC treatment alleviated hepatic steatosis and reduced serum TG and TC concentration significantly in OA fed rats. Hepatic lipogenic enzymes, such as fatty acid synthase (FAS), malic enzyme (ME), and glucose-6-phosphate dehydrogenase (G6PDH) activities were inhibited by SSC treatment. SSC also decreased the gene expression of FAS, ME, G6PDH and sterol-regulatory element binding protein (SREBP-1c). Otherwise, the rats feeding with SSC showed increased carnitine palmitoyl transferase (CPT) activity in the liver. Hepatic peroxisome proliferator-activated receptor (PPARα), together with its target gene CPT and acyl-CoA oxidase (ACO) mRNA expression were also upregulated by SSC. CONCLUSIONS: According to our study, the lipids-lowering effect of dietary SSC may be partly associated with the enhancement of β-oxidation via PPARα activation. In addition, the inhibited SREBP-1c- mediated lipogenesis caused by SSC may also contribute to alleviating fatty liver. BioMed Central 2010-03-09 /pmc/articles/PMC2846940/ /pubmed/20211032 http://dx.doi.org/10.1186/1476-511X-9-25 Text en Copyright ©2010 Hu et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Hu, Xiao-Qian
Wang, Yu-Ming
Wang, Jing-Feng
Xue, Yong
Li, Zhao-Jie
Nagao, Koji
Yanagita, Teruyoshi
Xue, Chang-Hu
Dietary saponins of sea cucumber alleviate orotic acid-induced fatty liver in rats via PPARα and SREBP-1c signaling
title Dietary saponins of sea cucumber alleviate orotic acid-induced fatty liver in rats via PPARα and SREBP-1c signaling
title_full Dietary saponins of sea cucumber alleviate orotic acid-induced fatty liver in rats via PPARα and SREBP-1c signaling
title_fullStr Dietary saponins of sea cucumber alleviate orotic acid-induced fatty liver in rats via PPARα and SREBP-1c signaling
title_full_unstemmed Dietary saponins of sea cucumber alleviate orotic acid-induced fatty liver in rats via PPARα and SREBP-1c signaling
title_short Dietary saponins of sea cucumber alleviate orotic acid-induced fatty liver in rats via PPARα and SREBP-1c signaling
title_sort dietary saponins of sea cucumber alleviate orotic acid-induced fatty liver in rats via pparα and srebp-1c signaling
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2846940/
https://www.ncbi.nlm.nih.gov/pubmed/20211032
http://dx.doi.org/10.1186/1476-511X-9-25
work_keys_str_mv AT huxiaoqian dietarysaponinsofseacucumberalleviateoroticacidinducedfattyliverinratsviapparaandsrebp1csignaling
AT wangyuming dietarysaponinsofseacucumberalleviateoroticacidinducedfattyliverinratsviapparaandsrebp1csignaling
AT wangjingfeng dietarysaponinsofseacucumberalleviateoroticacidinducedfattyliverinratsviapparaandsrebp1csignaling
AT xueyong dietarysaponinsofseacucumberalleviateoroticacidinducedfattyliverinratsviapparaandsrebp1csignaling
AT lizhaojie dietarysaponinsofseacucumberalleviateoroticacidinducedfattyliverinratsviapparaandsrebp1csignaling
AT nagaokoji dietarysaponinsofseacucumberalleviateoroticacidinducedfattyliverinratsviapparaandsrebp1csignaling
AT yanagitateruyoshi dietarysaponinsofseacucumberalleviateoroticacidinducedfattyliverinratsviapparaandsrebp1csignaling
AT xuechanghu dietarysaponinsofseacucumberalleviateoroticacidinducedfattyliverinratsviapparaandsrebp1csignaling